Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

By Søiland Håvard   Skaland Ivar   Varhaug Jan Erik   Kørner Hartwig   Janssen Emiel   Gudlaugsson Einar   Baak Jan   Søreide Jon Arne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 514-521

Informa Healthcare

Access to resources Recommend Favorite

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1467-1474

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

By Kurosumi Masafumi   Takatsuka Yuichi   Watanabe Toru   Imoto Shigeru   Inaji Hideo   Tsuda Hitoshi   Akiyama Futoshi   Sakamoto Goi   Ikeda Tadashi   Noguchi Shinzaburo  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 6, 2008-06 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept

By Iwata Hiroji  

Breast Cancer, Vol. 18, Iss. 2, 2011-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite